NCT04466033Completed
Evaluation of the Safety and Performance of Magneto Microcatheter
Evaluation of the Safety and Performance of Magneto Microcatheter for Endovascular Thrombectomy in Patients With Acute Ischemic Stroke
Source: ClinicalTrials.gov · Last updated 7 May 2025
Brief summary (registry, in English)
A prospective, open label single arm feasibility study to evaluate the safety and performance of the Magneto Microcatheter in patients diagnosed with acute ischemic stroke and planned for thrombectomy procedure.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 4 (actual)
- First submitted
- 5 Jul 2020
- Start date
- 1 Nov 2020
- Primary completion date
- 1 Apr 2024
- Lead sponsor
- Magneto Thrombectomy Solutions
- Diseases
- Stroke
- NCT number
- NCT04466033
What you commit to
- Study type: Interventional
- Participants enrolled: 4
- From 1 Nov 2020 to the primary completion date, 1 Apr 2024
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known bleeding diathesis
- Uncontrolled hypertension (Systolic blood pressure\>185 or Diastolic blood pressure\>110) refractory to pharmacological management
- CT scan or MRI with evidence of acute intracranial hemorrhage, ASPECT score\<6, mass effect and/or intracranial tumor
- Angiographic evidence of either carotid dissection or vasculitis at the target site or any condition that may limit device access to the target site (i.e high grade stenosis) per the treating physician's discretion.
Lab values
- Current use of oral anticoagulants with International Normalized Ratio (INR) \> 3;
- PTT (Partial Thromboplastin Time)\>2 at screening
Other
- Known use of cocaine or other vasoactive substance
- Any known hemorrhagic or coagulation deficiency.
- Pregnant or lactating female
Who the study is looking for
- Clinical signs consistent with acute ischemic stroke
- Patient with Acute Ischemic Stroke within 24 hours from symptoms o
- Age 18-85 years old
- Consent process is completed per international and local regulations
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institute of Mental Health, Neurology and Neurosurgery) Coordinator of this site? Confirm its status | Budapest | Hungary | Unknown status |
| Shaare Zedek Coordinator of this site? Confirm its status | Jerusalem | Israel | Unknown status |
| Sheba medical center Coordinator of this site? Confirm its status | Ramat Gan | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.